NOVOPROTEIN

Novoprotein is a biotech company founded in 2004, known for redefining excellence in recombinant protein services. Their offerings span a wide range of recombinant proteins, including growth factors, immune checkpoints, cytokines, chemokines, enzymes, and hormones. What sets Novoprotein apart is its specialization in contract research, offering custom protein production and expression, antibody production, protein modification, and protein crystallization services. As a player in the Biotechnology, Health Care, and Pharmaceutical industries, Novoprotein caters to the growing demand for advanced protein services in research and innovation. Being a niche service provider, Novoprotein presents an enticing opportunity for investors seeking exposure in the biotech sector.